G. Meyer - Concepedia

Author

G. Meyer

Also Known As

G M Bohns Meyer, G MEYER, G Meyer, G. Meyer, G.M. Bohns Meyer, Gisela M B Meyer, Gisela M. Bohns Meyer, Gisela M.B. Meyer, Gisela Martina Bohns Meyer, Gisela Meyer

Publications

Citations

H-Index

Concepts

All Affiliations

Santa Casa Hospital Medizinische Hochschule Hannover German Center for Lung Research Bicêtre Hospital Michigan Medicine

About

G. Meyer is an author at Santa Casa Hospital specializing in pharmacotherapy, pulmonary vascular disease, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	3	316
2	Public Health	2	3	316
3	Pharmacology	2	3	316
4	Hypertension	2	3	316
5	Pulmonary Medicine	1	1	14

G. Meyer

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension Marius M. Hoeper, David B. Badesch, Hossein Ardeschir Ghofrani, New England Journal of Medicine	2023	557
Sotatercept for the Treatment of Pulmonary Arterial Hypertension Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs, New England Journal of Medicine	2021	521
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension Vallerie V. McLaughlin, Richard N. Channick, Hossein Ardeschir Ghofrani, European Respiratory Journal	2015	224
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza, The Lancet Respiratory Medicine HypertensionPulmonary Arterial HypertensionPhosphodiesterase-5 InhibitorsCardiovascular DiseaseMedicine	2021	151
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial R. James White, Carlos Jerjes‐Sánchez, G. Meyer, American Journal of Respiratory and Critical Care Medicine	2019	142
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs, European Respiratory Journal	2022	138
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients Gérald Simonneau, Nazzareno Galiè, Pavel Jansa, International Journal of Cardiology	2014	57
Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study D. Dunbar Ivy, Damien Bonnet, Rolf M.F. Berger, Pulmonary Circulation	2021	19
Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension Akram Khan, R. James White, G. Meyer, Respiratory Medicine HypertensionPharmacotherapyPreventive CardiologyThrombosisPulmonary Pharmacology	2022	14

Page 1